|
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
|
journal
|
February 2020 |
|
Glycosylation of Therapeutic Proteins: An Effective Strategy to Optimize Efficacy
|
journal
|
January 2010 |
|
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
|
journal
|
February 2020 |
|
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets
|
journal
|
April 2014 |
|
Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin
|
journal
|
January 2008 |
|
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
|
journal
|
April 2020 |
|
Glycoproteomics Analysis of Human Liver Tissue by Combination of Multiple Enzyme Digestion and Hydrazide Chemistry
|
journal
|
February 2009 |
|
Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc
|
journal
|
April 2008 |
|
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2
|
journal
|
May 2020 |
|
Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2
|
journal
|
August 2018 |
|
Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2
|
journal
|
May 2020 |
|
Database Analysis of O-Glycosylation Sites in Proteins
|
journal
|
February 2001 |
|
Expression of 9- O - and 7,9- O -Acetyl Modified Sialic Acid in Cells and Their Effects on Influenza Viruses
|
journal
|
December 2019 |
|
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus
|
journal
|
January 2020 |
|
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
|
journal
|
March 2020 |
|
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
|
journal
|
August 2020 |
|
Determination of true ratios of different N-glycan structures in electrospray ionization mass spectrometry
|
journal
|
March 2017 |
|
Tool for Rapid Analysis of Glycopeptide by Permethylation via One-Pot Site Mapping and Glycan Analysis
|
journal
|
October 2017 |
|
Angiotensin-Converting Enzyme 2 Ectodomain Shedding Cleavage-Site Identification: Determinants and Constraints
|
journal
|
May 2011 |
|
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|
journal
|
February 2020 |
|
Site-specific glycan analysis of the SARS-CoV-2 spike
|
journal
|
May 2020 |
|
Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry
|
journal
|
June 2010 |
|
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
|
journal
|
July 2005 |
|
Structural basis for human coronavirus attachment to sialic acid receptors
|
journal
|
June 2019 |
|
Glycomic and glycoproteomic analysis of glycoproteins—a tutorial
|
journal
|
June 2017 |
|
Structural basis of receptor recognition by SARS-CoV-2
|
journal
|
March 2020 |
|
The proximal origin of SARS-CoV-2
|
journal
|
March 2020 |
|
A Human Homolog of Angiotensin-converting Enzyme
|
journal
|
October 2000 |
|
Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein
|
journal
|
September 2017 |
|
Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB
|
journal
|
April 2020 |
|
A Proteomic Analysis of Human Bile
|
journal
|
July 2004 |
|
GlycoFi's technology to control the glycosylation of recombinant therapeutic proteins
|
journal
|
December 2009 |
|
Database Analysis of O-Glycosylation Sites in Proteins
|
journal
|
February 2001 |
|
Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor
|
journal
|
July 2004 |
|
Unravelling the Role of O-glycans in Influenza A Virus Infection
|
journal
|
November 2018 |
|
Concepts and Principles of O-Linked Glycosylation
|
journal
|
January 1998 |
|
Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry
|
journal
|
May 2005 |
|
GlyGen: Computational and Informatics Resources for Glycoscience
|
journal
|
October 2019 |
|
Receptor recognition and cross-species infections of SARS coronavirus
|
journal
|
October 2013 |
|
Intact glycopeptide characterization using mass spectrometry
|
journal
|
April 2016 |
|
Mass spectrometric glycan rearrangements
|
journal
|
May 2011 |
|
Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry
|
journal
|
June 2008 |
|
Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors
|
journal
|
December 2019 |
|
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
|
journal
|
September 2020 |
|
Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
|
journal
|
October 2020 |
|
ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis
|
journal
|
January 2004 |
|
Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2
|
journal
|
July 2020 |
|
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
|
journal
|
May 2020 |
|
A pneumonia outbreak associated with a new coronavirus of probable bat origin
|
journal
|
February 2020 |
|
The structures of glycophorin C N-glycans, a putative component of the GPC receptor site for Plasmodium falciparum EBA-140 ligand
|
journal
|
December 2014 |
|
Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression
|
journal
|
March 2015 |
|
ADAM17 inhibition may exert a protective effect on COVID-19
|
journal
|
April 2020 |
|
Expression of 9- O - and 7,9- O -Acetyl Modified Sialic Acid in Cells and Their Effects on Influenza Viruses
|
journal
|
December 2019 |
|
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
|
journal
|
September 2000 |
|
COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children
|
journal
|
April 2020 |
|
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
|
journal
|
April 2020 |
|
Simplifying Glycan Profiling through a High-Throughput Micropermethylation Strategy
|
journal
|
May 2020 |
|
Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia
|
journal
|
July 2009 |
|
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
|
journal
|
November 2003 |
|
Inhibition of Endoplasmic Reticulum-Resident Glucosidases Impairs Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63 Spike Protein-Mediated Entry by Altering the Glycan Processing of Angiotensin I-Converting Enzyme 2
|
journal
|
October 2014 |
|
Highly Conserved Regions within the Spike Proteins of Human Coronaviruses 229E and NL63 Determine Recognition of Their Respective Cellular Receptors
|
journal
|
September 2006 |